Liraglutide, a human GLP-1 analogue, significantly improves beta cell function in subjects with type 2 diabetes

Podobné jednotky

• Liraglutide, a human GLP-1 analogue, reduces bodyweight in subjects with type 2 diabetes, irrespective of body mass index at baseline
  Autor: Schmitz, O, a další
  Vydáno: (2008)
• The reduction of body weight with liraglutide, a once-daily human GLP-I analogue for type 2 diabetes, primarily comes from fat tissue and the fat tissue lost is predominantly visceral fat
  Autor: Jendle, J, a další
  Vydáno: (2008)
• Liraglutide, a once-daily human GLP-1 analogue, in type 2 diabetes provides similar glycaemic control with reduced body weight compared with glimepiride when added to metformin
  Autor: Hermansen, K, a další
  Vydáno: (2008)
• Liraglutide, a human GLP-1 analogue, lowers HbA(1c) independent of weight loss
  Autor: Schmidt, W, a další
  Vydáno: (2009)
• Efficacy and safety comparison of liraglutide, glimepiride, and placebo, all in combination with metformin, in type 2 diabetes: the LEAD (liraglutide effect and action in diabetes)-2 study.
  Autor: Nauck, M, a další
  Vydáno: (2009)